COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor, in combination with a Kirsten rat sarcoma (KRAS) inhibitor. La présente divulgation concerne des méthodes de traitement du cancer par administratio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ROACH, Jeremy, SHVARTSBART, Artem, RIOS-DORIA, Jonathan, ZHU, Wenyu, MIN, Chang, WANG, Xiaozhao, SUSICK, Robert, ZHANG, Fenglei, QI, Chao, WANG, Hui, WEE, Susan, GAN, Pei, LAW, Chunyin Marshall, YANG, Jeffrey C, SOKOLSKY, Alexander, YE, Qinda, POLAM, Padmaja, ZHAO, Le, LI, Yong, MCCAMMANT, Matthew, POLICARPO, Rocco, LI, Gencheng, YIN, Haolin, HOANG, Gia, ABDOLLAHI, Angela, CARLSEN, Peter, HU, Bin, ARJONA, Alejandro Amador, FAVATA, Margaret, HE, Chunhong, YAO, Wenqing
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor, in combination with a Kirsten rat sarcoma (KRAS) inhibitor. La présente divulgation concerne des méthodes de traitement du cancer par administration d'un composé, qui est un inhibiteur du récepteur du facteur de croissance des fibroblastes (FGFR), en combinaison avec un inhibiteur du sarcome de rat de Kirschner (KRAS).